Effects of Product Format on Nicotine and TSNA Extraction from Snus Pouches

Size: px
Start display at page:

Download "Effects of Product Format on Nicotine and TSNA Extraction from Snus Pouches"

Transcription

1 Effects of Product Format on Nicotine and TSNA Extraction from Snus Pouches Nathan Gale, Graham Errington and Kevin McAdam Group Research & Development, British American Tobacco, Southampton, UK 67th Tobacco Science Research Conference, Williamsburg, VA, September

2 Introduction Background and Objective Methods - Approach for estimating exposure - Study design - Study protocol - Chemical & statistical analysis Results - Mass and percentage - Effects on extraction of nicotine, NNN and NNK - Comparison with literature Summary 2

3 Background and Objective Understanding Exposure Understanding quantity of constituents during snus use is an important step in estimating exposure - STPs, NNN and NNK identified as Group 1 carcinogens by IARC - Nicotine, NNN and NNK feature on FDA HPHC list A number of factors are likely to affect extraction - Product format, human use behaviours, constituents Our previous studies of pouched snus have concentrated on a single product - To allow evaluation of effects of human and constituent factors on extraction 3

4 Methods Approach for Estimating Exposure Constituent levels in used snus portions compared with levels in unused portions Amount and extent of extraction calculated: Amount Extracted = Quantity in Unused Snus Quantity in Used Snus % Extracted = (Amount Extracted / Quantity in Unused Snus)*100 4

5 Methods Study Design Study designed to assess effects of pouch mass (3 levels), moisture content (2 levels) and flavour (3 levels) on extraction - Balanced incomplete block design 18 test pieces manufactured specifically for this study - No effect of flavour level on nicotine, NNN or NNK extraction, therefore data for products with same pouch size and moisture content combined here Product Pouch mass (g ± tolerance) Moisture content (% ± tolerance) Product style ± ± 2 Brown ± ± 2 Brown ± ± 2 Brown ± ± 2 White ± ± 2 White ± ± 2 White 5

6 Methods Study Protocol Central Location study in Stockholm, Sweden 18 male snus users aged completed the study - Each volunteer provided informed consent and was reimbursed for time and travel Controlled intake before and during study - No food or tobacco product consumption 1 hour prior to attendance - No food or drink during session, other than option of water between samples - Snus pouch held in mouth by subjects for 60 minutes 1 Control (unused) pouches taken from same tin as test sample at same time Post-use, snus samples transported frozen in individual glass vials 1 Digard, H., Errington, G., Richter, A. and McAdam, K. Nicotine and Tobacco Research :

7 Methods Chemical and Statistical Analysis Validated multi-analyte extraction method 1 used to examine multiple constituents from same snus pouch - Each pouch in methanol and centrifuged - Aliquot analysed for nicotine by GC-MS - Second aliquot analysed for TSNAs by LC-MS/MS Extraction values calculated for each pair of pouches - General Linear Model used to assess effects of pouch mass and moisture content 1 Digard, H., Gale, N., Errington, G., Peters, N. and McAdam, K. Chemistry Central Journal :55 7

8 Results Mass Extracted pouch mass (g ± SD) moisture content nicotine (mg ± SD) NNN (ng ± SD) NNK (ng ± SD) 0.5 ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± 16.7 N = due to sample administration error and laboratory losses, except for moisture content where N=6 and determined on tobacco removed from pouches 8

9 Results Percentage Extracted pouch mass (g ± SD) moisture content nicotine NNN NNK 0.5 ± ± ± ± ± ± ± ± ± 9 36 ± ± ± ± ± 9 33 ± ± ± ± 8 23 ± 8 24 ± ± ± ± ± ± ± ± ± 7 22 ± 8 22 ± 7 Changes to pouch mass and moisture content appear to affect NNN and NNK extraction in the same way as they do nicotine extraction 9

10 Results Percentage Extracted pouch mass (g ± SD) moisture content nicotine NNN NNK 0.5 ± ± ± 15 a 40 ± 12 a 43 ± 12 a 1.0 ± ± ± 11 a 35 ± 9 b 36 ± 8 ab 1.5 ± ± ± 11 a 32 ± 9 b 33 ± 9 ab 0.5 ± ± ± 8 a 23 ± 8 b 24 ± 9 b 1.0 ± ± ± 13 a 26 ± 12 b 26 ± 13 b 1.3 ± ± ± 7 a 22 ± 8 b 22 ± 7 b Changes to pouch mass and moisture content appear to affect NNN and NNK extraction in the same way as they do nicotine extraction - One-way ANOVA shows NNN and NNK to a lesser extent than nicotine (p<0.05) for 45% moisture content pouches 10

11 Results Percentage Extracted pouch mass (g ± SD) moisture content nicotine NNN NNK 0.5 ± ± ± 15 a 40 ± 12 a 43 ± 12 a 1.0 ± ± ± 11 a 35 ± 9 b 36 ± 8 ab 1.5 ± ± ± 11 a 32 ± 9 b 33 ± 9 ab 0.5 ± ± ± 8 a 23 ± 8 b 24 ± 9 b 1.0 ± ± ± 13 a 26 ± 12 b 26 ± 13 b 1.3 ± ± ± 7 a 22 ± 8 b 22 ± 7 b Changes to pouch mass and moisture content appear to affect NNN and NNK extraction in the same way as they do nicotine extraction - One-way ANOVA shows NNN and NNK to a lesser extent than nicotine (p<0.05) for 45% moisture content pouches 11

12 Results Effects on Extraction of Nicotine Increase in pouch mass = increase in mass of nicotine and a decrease in percentage nicotine Increase in moisture content = increase in mass of nicotine and an increase in percentage nicotine 12

13 Results Effects on Extraction of NNN and NNK 13

14 Results Comparison with literature Lunell & Lunell 1 reported extraction of nicotine from four different pouched snus products Mass / Moisture / Style Nicotine Extraction (%) This BAT study Lunell & Lunell 0.5g / 52% / Brown 45 ± 15 (n=50) 44 (n=12) 1.0g / 52% / Brown 40 ± 11 (n=54) 31 (n=12) 1.5g / 52% / Brown 37 ± 11 (n=54) - 0.5g / 45% / White 31 ± 8 (n=52) 22 (n=12) [0.3g, 25%] 1.0g / 45% / White 33 ± 13 (n=53) 22 (n=12) 1.3g / 45% / White 27 ± 7 (n=54) - Supported by the findings of the current study - Decrease in moisture content results in lower percentage extraction - Increase in pouch mass leads to lower percentage extraction 1 Lunell, E. and Lunell, M. Nicotine and Tobacco Research :

15 Summary Extraction of nicotine, NNN and NNK from pouched snus is incomplete (<50% of unused pouch content) Both pouch mass and moisture content measurably influence extraction of nicotine, NNN and NNK from snus during use - Increase in pouch mass results in decreased extraction efficiency but in increased total exposure - Increase in moisture content results in increased extraction efficiency and total exposure 15

16 Acknowledgements GfK Sverige AB Fieldwork Research Support Services staff at GR&D, British American Tobacco - Tim John Wheeler Product manufacturing - Nicola Peters Method development and sample analysis - Donna Byrom Method development and sample analysis - Paul Blachford Sample analysis - Margaret Spence Sample analysis - Cheryl Johns Sample analysis - Maria Carradus Sample analysis 16

Nicotine Pharmacokinetics: Comparison of a cigarette, loose snus, pouched snus and nicotine gum

Nicotine Pharmacokinetics: Comparison of a cigarette, loose snus, pouched snus and nicotine gum ST14-2011 CORESTA Smoke Science/ Product Technology 9 13 October 2011 Graz, Austria Nicotine Pharmacokinetics: Comparison of a cigarette, loose, pouched and nicotine gum H. Digard a, C. Proctor a, U. Malmqvist

More information

The Effect of Puff Profile and Volume on the Yields of E-Cigarettes

The Effect of Puff Profile and Volume on the Yields of E-Cigarettes The Effect of Puff Profile and Volume on the Yields of E-Cigarettes Dr M J Taylor, Filtrona Technology Centre Smoke Science/Product Technology Meeting Seville, Spain, 29 September to 03 October 2013 Introduction

More information

SNUS and the GOTHIATEK STANDARD

SNUS and the GOTHIATEK STANDARD SNUS and the GOTHIATEK STANDARD Inger Wahlberg Consulting 1 SNUS 2 SNUS 3 Snus Swedish snus A moist to semi-moist oral tobacco product, traditionally produced and used in Sweden. Contains finely ground,

More information

2017_ST10_JinCathy.pdf. SSPT Document not peer-reviewed by CORESTA

2017_ST10_JinCathy.pdf. SSPT Document not peer-reviewed by CORESTA Investigation of TSNA Formation in Electronic Cigarette Liquids and Aerosols Xiaohong Cathy Jin, Karen C. Avery, Georgios D. Karles, William P. Gardner, Matt S. Melvin, Donna C. Smith, Willie J. Mckinney,

More information

Development and Validation of an UPLC-MS/MS Method for Quantification of Mycotoxins in Tobacco and Smokeless Tobacco Products

Development and Validation of an UPLC-MS/MS Method for Quantification of Mycotoxins in Tobacco and Smokeless Tobacco Products Development and Validation of an UPLC-MS/MS Method for Quantification of Mycotoxins in Tobacco and Smokeless Tobacco Products Johan Lindholm, Anna Wiernik, Birgitta Grandin, Margareta Curvall Swedish Match

More information

NNN Levels in Stable Reduced Converter (SRC) and LC lines cured under conditions that favor NNN formation.

NNN Levels in Stable Reduced Converter (SRC) and LC lines cured under conditions that favor NNN formation. NNN Levels in Stable Reduced Converter (SRC) and LC lines cured under conditions that favor NNN formation. M. Lusso; K. Lion; A. Adams; W. Morris; U. Warek and J. Strickland Altria Client Services (ALCS)

More information

Air Quality assessment during indoor use of the Tobacco Heating System 2.2

Air Quality assessment during indoor use of the Tobacco Heating System 2.2 Air Quality assessment during indoor use of the Tobacco Heating System 2.2 THS 2.2. is commercialized under the IQOS brand name Dr Catherine Goujon Ginglinger - Philip Morris International Research & Development,

More information

Human mouth-level transfer rate of menthol, 1.8-cineole and nicotine from Swedish pouched snus

Human mouth-level transfer rate of menthol, 1.8-cineole and nicotine from Swedish pouched snus Human mouth-level transfer rate of menthol, 1.8-cineole and nicotine from Swedish pouched snus V. Troude 1, S. Gadois-Pommereul 1, A. Clarke 2, L. Simms 2 1. SEITA, Imperial Tobacco Group, 48 rue Danton,

More information

Development and Validation of a Portable Puffing Topography Analyser

Development and Validation of a Portable Puffing Topography Analyser Development and Validation of a Portable Puffing Topography Analyser Gee J.; Slayford S.; Vas C.; Prasad K CORESTA SSPT 2015 R&D British American Tobacco, Southampton, UK Outline Background & Objective

More information

MODIFIED RISK TOBACCO PRODUCT MARKETING DECISIONS

MODIFIED RISK TOBACCO PRODUCT MARKETING DECISIONS MODIFIED RISK TOBACCO PRODUCT MARKETING DECISIONS Presented by David Ashley, Ph.D. Rear Admiral (retired), US Public Health Service Director, Office of Science, CTP, FDA Disclaimer: This is not a formal

More information

Toxic Contents and Emissions in Smokeless Tobacco Products

Toxic Contents and Emissions in Smokeless Tobacco Products Article 9 and 10 Toxic Contents and Emissions in Smokeless Tobacco Products www.untobaccocontrol.org/kh/smokeless-tobacco/ Article 9 and 10 Contents What is Article 9 & 10. Current Status Regarding Implementation

More information

Global impact of FDA-inspired tobacco regulatory science on jobs for chemists

Global impact of FDA-inspired tobacco regulatory science on jobs for chemists Global impact of FDA-inspired tobacco regulatory science on jobs for chemists Sarah Cooney and Chris Proctor Group Research & Development, British American Tobacco, UK American Chemical Society Fall Meeting,

More information

Cardiovascular effects of nicotine vs. cigarette smoke

Cardiovascular effects of nicotine vs. cigarette smoke Cardiovascular effects of nicotine vs. cigarette smoke Dr Konstantinos Farsalinos Researcher Onassis Cardiac Surgery Center, Greece University of Patras, Greece National School of Public Health, Athens-Greece

More information

SPIT TOBACCO & SPITLESS TOBACCO

SPIT TOBACCO & SPITLESS TOBACCO SPIT TOBACCO & SPITLESS TOBACCO Spit tobacco (often called smokeless by the tobacco industry) is being marketed as a safe alternative to smoking, but SMOKELESS IS NOT HARMLESS! Spit Tobacco Chewing tobacco

More information

Technical Report. CORESTA Reference Products

Technical Report. CORESTA Reference Products Smokeless Tobacco Sub-Group Technical Report CORESTA Reference Products 2016 Analysis January 2017 Study Coordinator: John Bunch, Ph.D. American Snuff Company, USA Author and Sub-Group Coordinator: Karl

More information

Low-Nitrosamine Dissolvable Tobacco Products Star Scientific, Inc. Part III Initiation and Cessation

Low-Nitrosamine Dissolvable Tobacco Products Star Scientific, Inc. Part III Initiation and Cessation Low-Nitrosamine Dissolvable Tobacco Products Star Scientific, Inc. Part III Initiation and Cessation Using science to reduce tobacco-related harm at every level of the population 1 Summary - Parts I &

More information

Nicotine delivery from e-cigarettes part II: data and learnings from two pharmacokinetic studies.

Nicotine delivery from e-cigarettes part II: data and learnings from two pharmacokinetic studies. LOS ANGELES CLINICAL TRIALS Nicotine delivery from e-cigarettes part II: data and learnings from two pharmacokinetic studies. Ian M. Fearon, Alison Eldridge, Nathan Gale, Christopher J. Shepperd, Mike

More information

UPDATE ON PREMARKET TOBACCO PRODUCT AUTHORIZATION PATHWAY

UPDATE ON PREMARKET TOBACCO PRODUCT AUTHORIZATION PATHWAY UPDATE ON PREMARKET TOBACCO PRODUCT AUTHORIZATION PATHWAY Presented by Ii-Lun Chen, M.D Director Division of Individual Health Science Office of Science, CTP, FDA Disclaimer: This is not a formal dissemination

More information

July 10, Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852

July 10, Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852 July 10, 2017 Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852 Comments on Food and Drug Administration Docket No. FDA-2016-N-2527,

More information

Ian M. Fearon, Madeleine Ashley, Christopher J. Shepperd, Graham Errington. Sheri A. Bowman, John W. Caraway, Peter Chen, Paul R.

Ian M. Fearon, Madeleine Ashley, Christopher J. Shepperd, Graham Errington. Sheri A. Bowman, John W. Caraway, Peter Chen, Paul R. Influence of Cigarette Filter Ventilation on Smokers Mouth Level Exposure to Tar and Nicotine: A Retrospective Meta-Analysis of 11 Studies in 9 Countries Ian M. Fearon, Madeleine Ashley, Christopher J.

More information

TNCO Testing procedures

TNCO Testing procedures TNCO Testing procedures Chris Proctor Pete Davis British American Tobacco Group R&D UK US FDA Center for Tobacco Products Scientific Workshop 30-31 July 2013 1 A. Describe the different extraction steps

More information

E-cigarette consumption and puffing topography data. Dr Sudhanshu Patwardhan FDA CTP Workshop, Hyattsville, Maryland. March 9, 2015.

E-cigarette consumption and puffing topography data. Dr Sudhanshu Patwardhan FDA CTP Workshop, Hyattsville, Maryland. March 9, 2015. E-cigarette consumption and puffing topography data Dr Sudhanshu Patwardhan FDA CTP Workshop, Hyattsville, Maryland. March 9, 2015. Outline Nicoventures Introduction Topography and use patterns to inform

More information

Public consultation on SCENIHR preliminary report on "Health Effects of Smokeless Tobacco Products"

Public consultation on SCENIHR preliminary report on Health Effects of Smokeless Tobacco Products Public consultation on SCENIHR preliminary report on "Health Effects of Smokeless Tobacco Products" Please find below the questions posed by the Commission and the answers given by the Committee. These

More information

Air Quality assessment during indoor use of the Tobacco Heating System 2.2

Air Quality assessment during indoor use of the Tobacco Heating System 2.2 Air Quality assessment during indoor use of the Tobacco Heating System 2.2 THS 2.2. is commercialized under the IQOS brand name Maya Mitova, Catherine Goujon Ginglinger, Michel Rotach, Serge Maeder Philip

More information

Dissolvable Tobacco Products: Chemistry & Toxicology

Dissolvable Tobacco Products: Chemistry & Toxicology Dissolvable Tobacco Products: Chemistry & Toxicology Tobacco Products Scientific Advisory Committee July 21-22, 2011 Charles D. Garner, Ph.D., DABT, CIH Sr. Director, Regulatory Oversight Presentation

More information

WHO work on smokeless tobacco. Dr Vinayak Prasad, WHO HQ Ms Sarah Emami, WHO HQ

WHO work on smokeless tobacco. Dr Vinayak Prasad, WHO HQ Ms Sarah Emami, WHO HQ WHO work on smokeless tobacco Dr Vinayak Prasad, WHO HQ Ms Sarah Emami, WHO HQ WHO provides technical assistance to Member States on SLT policies and programs: MPOWER package ( key demand reduction measures

More information

Effect of Sugars on Selected Toxicant Yields in e-cigarettes

Effect of Sugars on Selected Toxicant Yields in e-cigarettes CORESTA Congress, 11th October 2016, Berlin Effect of Sugars on Selected Toxicant Yields in e-cigarettes Jennifer Margham 1, Kevin McAdam 1 ST 31 BERLIN 2016 1 British American Tobacco, Group R&D, Southampton,

More information

The concept that not all tobacco and nicotine products

The concept that not all tobacco and nicotine products A Model Risk Continuum for Tobacco and Nicotine Products by Chris Proctor, Sudhanshu Patwardhan, and James Murphy The concept that not all tobacco and nicotine products present the same risks to human

More information

Technical Report. Analysis of Moisture Content (Oven Volatiles) of Smokeless Tobacco Products

Technical Report. Analysis of Moisture Content (Oven Volatiles) of Smokeless Tobacco Products Smokeless Tobacco Sub-Group Technical Report Analysis of Moisture Content (Oven Volatiles) of Smokeless Tobacco Products 2010 Collaborative and Proficiency Studies March 2014 Author and Sub-Group Secretary:

More information

CORESTA Recommended Method No. 76

CORESTA Recommended Method No. 76 Cooperation Centre for Scientific Research Relative to Tobacco Tobacco and Tobacco Products Analytes Sub-Group CORESTA Recommended Method No. 76 DETERMINATION OF MOISTURE CONTENT (OVEN VOLATILES) OF TOBACCO

More information

Smoke Analytes Sub-Group (SMA) 2017 Report

Smoke Analytes Sub-Group (SMA) 2017 Report Smoke Analytes Sub-Group (SMA) 2017 Report Smoke Science and Product Technology Study Groups Kitzbühel, October 11, 2017 SMA SG Sub-Group name change In January 2017, SG changed its name to Smoke Analytes

More information

Nicotine delivery from e-cigarettes part I: study designs for two pharmacokinetic studies.

Nicotine delivery from e-cigarettes part I: study designs for two pharmacokinetic studies. LOS ANGELES CLINICAL TRIALS Nicotine delivery from e-cigarettes part I: study designs for two pharmacokinetic studies. Ian M. Fearon, Alison Eldridge, Nathan Gale, Christopher J. Shepperd, Mike McEwan,

More information

SNUS ON THE LOOSE: Big Tobacco s s latest attempt to make nicotine more attractive

SNUS ON THE LOOSE: Big Tobacco s s latest attempt to make nicotine more attractive SNUS ON THE LOOSE: Big Tobacco s s latest attempt to make nicotine more attractive U.S. Smokeless Tobacco Market Historically the preserve of smaller, specialized companies: Conwood U.S. U.S. Smokeless

More information

New & Emerging Tobacco Products. Linda Bauld & Kamran Siddiqi

New & Emerging Tobacco Products. Linda Bauld & Kamran Siddiqi New & Emerging Tobacco Products Linda Bauld & Kamran Siddiqi Outline Electronic cigarettes Heat not burn tobacco Smokeless tobacco Waterpipes Terminology E-cigarettes are not a single product Debate about

More information

Tobacco Blend Style. Dinah Winter, Martin Coleman, Nigel Warren

Tobacco Blend Style. Dinah Winter, Martin Coleman, Nigel Warren Tobacco Blend Style Dinah Winter, Martin Coleman, Nigel Warren Tobacco Blends 100% lamina tobaccos: Virginia Burley (uncased) 50:50 Virginia/Burley Mix Oriental Examined: Blend component differences Relationships

More information

Cancer and its Causes in Korea

Cancer and its Causes in Korea Cancer and its Causes in Korea Prof. Dr. David Khayat, MD, PhD Former Head of Medical Oncology at Pitié-Salpêtrière in Paris Former President of the National Cancer Institute in France Harm Reduction Consultant

More information

Biomarker (BMK) Sub-Group 2017 Report

Biomarker (BMK) Sub-Group 2017 Report Biomarker (BMK) Sub-Group 2017 Report Kitzbühel, Austria October 10, 2017 Coordinator: G. L. Prasad Secretary: Kirk Newland Scientific Commission Liaison: Paul Harp Biomarker Sub-Group Objectives Objective

More information

FDLI Annual Conference

FDLI Annual Conference FDLI Annual Conference Panel Tobacco Harm Reduction: Opportunities & Regulatory Pathways to Achieve May 5, 2017 Joe Murillo Vice President, Regulatory Affairs Altria Client Services Panel Discussion at

More information

CORESTA Smokeless Tobacco Sub-Group Working Group Collaborative Study Report July 2010

CORESTA Smokeless Tobacco Sub-Group Working Group Collaborative Study Report July 2010 CORESTA Smokeless Tobacco Sub-Group Working Group 2 2009 Collaborative Study Report July 2010 (Updated January 2016) Study Coordinator: Linda Drake, British American Tobacco, Group R&D, Southampton, UK

More information

CORESTA Recommended Method No. 56

CORESTA Recommended Method No. 56 Cooperation Centre for Scientific esearch elative to Tobacco Tobacco and Tobacco Products Analytes Sub-Group COESTA ecommended Method No. 56 DETEMINATION OF WATE IN TOBACCO AND TOBACCO PODUCTS BY KAL FISCHE

More information

Development and validation of a device for measuring puffing topography of e-cigarette users

Development and validation of a device for measuring puffing topography of e-cigarette users Development and validation of a device for measuring puffing topography of e-cigarette users CUNNINGHAM A. 1 ; SLAYFORD S. 1 ; VAS C. 1 ; GEE J. 1 ; COSTIGAN S. 2 ; PRASAD K. 1 1 British American Tobacco,

More information

Novel tobacco products - snus. Karin Molander Gregory, Jur. kand., L.L.M., Public Health Planning Officer, Sweden

Novel tobacco products - snus. Karin Molander Gregory, Jur. kand., L.L.M., Public Health Planning Officer, Sweden Novel tobacco products - snus Karin Molander Gregory, Jur. kand., L.L.M., Public Health Planning Officer, Sweden Sales of snus and cigarettes in Sweden Snus [Tonnes] Cigarettes [Million pieces] 8000 14000

More information

Robust and Fast Analysis of Tobacco-Specific Nitrosamines by LC-MS/MS

Robust and Fast Analysis of Tobacco-Specific Nitrosamines by LC-MS/MS Application Note 242 Robust and Fast Analysis of Tobacco-Specific Nitrosamines by LC-MS/MS INTRODUCTION Tobacco-specific nitrosamines (TSNA) are a group of carcinogens found only in tobacco products. They

More information

Nicotine pharmacokinetics of electronic cigarettes: experimental data and a review of the literature

Nicotine pharmacokinetics of electronic cigarettes: experimental data and a review of the literature Nicotine pharmacokinetics of electronic cigarettes: experimental data and a review of the literature Ian M. Fearon, Alison Eldridge, Nathan Gale, Mike McEwan Paul R. Nelson, Mitch Stiles, Elaine Round

More information

The Family Smoking Prevention and Tobacco

The Family Smoking Prevention and Tobacco Call to Establish Constituent Standards for Smokeless Tobacco Products Irina Stepanov, PhD Dorothy Hatsukami, PhD Objectives: To summarize evidence supporting the establishment of constituent standards

More information

BRITISH AMERICAN TOBACCO Science & Technology report

BRITISH AMERICAN TOBACCO Science & Technology report BRITISH AMERICAN TOBACCO Science & Technology 2015 report Foreword 1 Dr David O Reilly, Group Scientific and R&D Director RESEARCH PRIORITIES Stewardship and next generation products 2 Dr Christopher Proctor

More information

Jennifer P. Pascali, PhD. dtolabs, Resana (TV)

Jennifer P. Pascali, PhD. dtolabs, Resana (TV) Jennifer P. Pascali, PhD dtolabs, Resana (TV) Agilent Technologies Users Meeting, 20 May 2014 The project dtolabs dtolabs is an analytical research centre founded by two leading companies in the production

More information

Evaluation of the Potential for Second-hand Exposure to E-cigarette Aerosol in an Office Environment

Evaluation of the Potential for Second-hand Exposure to E-cigarette Aerosol in an Office Environment Evaluation of the Potential for Second-hand Exposure to E-cigarette Aerosol in an Office Environment Edward A. Robinson, Robert D. Leverette, and Manoj Misra Lorillard Tobacco Company 68 th TSRC Charlottesville,

More information

Cigarettes Determination of tobacco specific nitrosamines in mainstream cigarette smoke Method using LC-MS/MS

Cigarettes Determination of tobacco specific nitrosamines in mainstream cigarette smoke Method using LC-MS/MS INTERNATIONAL STANDARD ISO 19290 First edition 2016-12-01 Cigarettes Determination of tobacco specific nitrosamines in mainstream cigarette smoke Method using LC-MS/MS Cigarettes Dosage des nitrosamines

More information

Communicating the Risk of Nicotine Delivery Products

Communicating the Risk of Nicotine Delivery Products Communicating the Risk of Nicotine Delivery Products August 10, 2014 ACS National Meeting Jim Solyst June 24, 2014 1 Nicotine Background Key Points The popularity of e-cigarettes has increased the need

More information

CORESTA Recommended Method No. 84

CORESTA Recommended Method No. 84 Cooperation Centre for Scientific Research Relative to Tobacco E-Vapour Sub-Group CORESTA Recommended Method No. 84 DETERMINATION OF GLYCERIN, PROPYLENE GLYCOL, WATER, AND NICOTINE IN THE AEROSOL OF E-CIGARETTES

More information

OVERALL HEALTH EFFECTS OF SWEDISH MATCH SNUS PRODUCTS

OVERALL HEALTH EFFECTS OF SWEDISH MATCH SNUS PRODUCTS OVERALL HEALTH EFFECTS OF SWEDISH MATCH SNUS PRODUCTS Lester Jao Lacorte, MD, CCRP Medical Officer Office of Science Center for Tobacco Products U.S. Food and Drug Administration DISCLAIMER 1 The information

More information

SMOKELESS TOBACCO/CHEWING TOBACCO TOOLKIT

SMOKELESS TOBACCO/CHEWING TOBACCO TOOLKIT SMOKELESS TOBACCO/CHEWING TOBACCO TOOLKIT Key Messages Smokeless (spit) tobacco is not a safe alternative to cigarettes. Smokeless tobacco is addictive. Smokeless tobacco contains over 3,000 chemicals,

More information

Carl D. D Ruiz 1*, Donald W. Graff 2 and Edward Robinson 3

Carl D. D Ruiz 1*, Donald W. Graff 2 and Edward Robinson 3 D Ruiz et al. BMC Public Health (2016) 16:543 DOI 10.1186/s12889-016-3236-1 RESEARCH ARTICLE Open Access Reductions in biomarkers of exposure, impacts on smoking urge and assessment of product use and

More information

Rapid and Accurate LC-MS/MS Analysis of Nicotine and Related Compounds in Urine Using Raptor Biphenyl LC Columns and MS-Friendly Mobile Phases

Rapid and Accurate LC-MS/MS Analysis of Nicotine and Related Compounds in Urine Using Raptor Biphenyl LC Columns and MS-Friendly Mobile Phases Clinical, Forensic & Toxicology Applications Rapid and Accurate LC-MS/MS Analysis of Nicotine and Related Compounds in Urine Using Raptor Biphenyl LC Columns and MS-Friendly Mobile Phases By Shun-Hsin

More information

TMA Annual Conference, Williamsburg, May 20-22, Public Health. The Swedish Experience

TMA Annual Conference, Williamsburg, May 20-22, Public Health. The Swedish Experience TMA Annual Conference, Williamsburg, May 20-22, 2012 Effects of Snus Use on Public Health The Swedish Experience Lars M. Ramström PhD Director, Institute for Tobacco Studies Stockholm, Sweden Email: lars.ramstrom@tobaccostudies.com

More information

Two Topics: Tobacco Control and Dietary Chemoprevention Stephen S. Hecht, Ph.D. February 3-5, 2016 Lansdowne Resort, Leesburg, VA

Two Topics: Tobacco Control and Dietary Chemoprevention Stephen S. Hecht, Ph.D. February 3-5, 2016 Lansdowne Resort, Leesburg, VA Two Topics: Tobacco Control and Dietary Chemoprevention Stephen S. Hecht, Ph.D. February 3-5, 2016 Lansdowne Resort, Leesburg, VA Outline Tobacco Control Policy Research Dietary Chemoprevention Percentage

More information

CORESTA RECOMMENDED METHOD NÄ 9

CORESTA RECOMMENDED METHOD NÄ 9 CORESTA RECOMMENDED METHOD NÄ 9 DETERMINATION OF NICOTINE IN CIGARETTE FILTERS BY GAS CHROMATOGRAPHIC ANALYSIS (April 2009) 0. INTRODUCTION In 2001 the CORESTA Routine Analytical Chemistry Sub-Group was

More information

Next Generation Products Sandra Costigan, Marianna Gaca, ChuanLiu, Kevin McAdam, James J. Murphyand Christopher Proctor British American Tobacco 21

Next Generation Products Sandra Costigan, Marianna Gaca, ChuanLiu, Kevin McAdam, James J. Murphyand Christopher Proctor British American Tobacco 21 Next Generation Products Sandra Costigan, Marianna Gaca, ChuanLiu, Kevin McAdam, James J. Murphyand Christopher Proctor British American Tobacco 21 st October 2015 Contents Evolution of products across

More information

Fatty acid profile analysis: Grape Seed Oil Sample Set Two ( )

Fatty acid profile analysis: Grape Seed Oil Sample Set Two ( ) Fatty acid profile analysis: Grape Seed Oil Sample Set Two (1-21-2014) Overview: Samples were provided of oil pressed from grape seeds and analysis of fatty acid content requested. Fatty acid profiles

More information

Nicotine Reduction Workshop Role of nicotine in smoking behaviour

Nicotine Reduction Workshop Role of nicotine in smoking behaviour Nicotine Reduction Workshop Role of nicotine in smoking behaviour Derek Mariner APSTW02 11 October 2016 2016 CORESTA Congress, Berlin, Germany, 9-13 October 2016 Introduction Nicotine itself is not especially

More information

Steady-state nicotine plasma levels following use of four different types of Swedish snus compared with 2-mg Nicorette chewing gum: A crossover study

Steady-state nicotine plasma levels following use of four different types of Swedish snus compared with 2-mg Nicorette chewing gum: A crossover study Nicotine & Tobacco Research Volume 7, Number 3 (May 2005) 1 7 Steady-state nicotine plasma levels following use of four different types of Swedish snus compared with 2-mg Nicorette chewing gum: A crossover

More information

Technical Report. Determination of Nitrate in Smokeless Tobacco Products by Continuous Flow Analysis

Technical Report. Determination of Nitrate in Smokeless Tobacco Products by Continuous Flow Analysis Smokeless Tobacco Sub-Group Technical Report Determination of Nitrate in Smokeless Tobacco Products by Continuous Flow Analysis 2010 Collaborative and Proficiency Studies January 2015 Author and Sub-Group

More information

A study to examine changes in exposure to cigarette smoke chemicals when a smoker switches to using a tobacco heating product. Part I: Study Design.

A study to examine changes in exposure to cigarette smoke chemicals when a smoker switches to using a tobacco heating product. Part I: Study Design. A study to examine changes in exposure to cigarette smoke chemicals when a smoker switches to using a tobacco heating product. Part I: Study Design. Nathan Gale 1, Mike McEwan 1, Alison Eldridge 1, Neil

More information

Modelling the effects of user exposure to harmful emissions across the spectrum of nicotine delivery

Modelling the effects of user exposure to harmful emissions across the spectrum of nicotine delivery Global Nicotine Forum 2018 Modelling the effects of user exposure to harmful emissions across the spectrum of nicotine delivery Ed Stephens University of St Andrews Declaration: No conflicts of interest

More information

Variation in Smoke Toxicant Yields from Selected Cigarettes

Variation in Smoke Toxicant Yields from Selected Cigarettes Variation in Smoke Toxicant Yields from Selected Cigarettes lison Eldridge (SSPT), Tatiana Betson (P), Kevin Mcdam 2013 COREST Joint Study Group Meetings SSPT Seville, Spain / 29 Sept - 3 Oct P Brufa di

More information

Procine sphingomyelin ELISA Kit

Procine sphingomyelin ELISA Kit Procine sphingomyelin ELISA Kit For the quantitative in vitro determination of Procine sphingomyelin concentrations in serum - plasma - celiac fluid - tissue homogenate - body fluid FOR LABORATORY RESEARCH

More information

Harmful and Potentially Harmful Constituents in Tobacco Products and Tobacco Smoke;

Harmful and Potentially Harmful Constituents in Tobacco Products and Tobacco Smoke; This document is scheduled to be published in the Federal Register on 04/03/2012 and available online at http://federalregister.gov/a/2012-07727, and on FDsys.gov 4160-01-P DEPARTMENT OF HEALTH AND HUMAN

More information

Acrylamide in Foods: An Important International Issue

Acrylamide in Foods: An Important International Issue Acrylamide in Foods: An Important International Issue 2013 Fera-JIFSAN Annual Symposium FDA, Harvey W. Wiley Bldg Auditorium College Park, MD June 12-13, 2013 Acrylamide in Foods Acrylamide - industrial

More information

Heated Tobacco Technology: Science, Behavior and Avoiding Unintended Consequences

Heated Tobacco Technology: Science, Behavior and Avoiding Unintended Consequences Heated Tobacco Technology: Science, Behavior and Avoiding Unintended Consequences Global Forum on Nicotine 2017 Moira Gilchrist PhD Philip Morris International June 16th 2017 Important Information Reduced-Risk

More information

How innovation will deliver a smokefree

How innovation will deliver a smokefree How innovation will deliver a smokefree future Innovation and Good Practices in the Health Sector Rui Minhos Head of Regional Scientific Engagement Philip Morris International 6th November 2018 Our contact

More information

Exploring five common claims about e-cigarette use. Lion Shahab, PhD University College

Exploring five common claims about e-cigarette use. Lion Shahab, PhD University College Exploring five common claims about e-cigarette use Lion Shahab, PhD University College London @LionShahab Claim 1: Renormalisation Claim 1: Renormalisation A priori predictions for impact on population

More information

Biomarkers in Public Health: Development and Applications

Biomarkers in Public Health: Development and Applications Biomarkers in Public Health: Development and Applications Irina Stepanov, Ph.D. Assistant Professor Division of Environmental Health Sciences and Masonic Cancer Center University of Minnesota Biomarker

More information

Determination of N-Nitrososarcosine (NSAR) in tobacco

Determination of N-Nitrososarcosine (NSAR) in tobacco JTI-Ökolab Vienna, Austria Determination of N-Nitrososarcosine (NSAR) in tobacco Madeleine Werneth, Jutta Pani, Bernhard Mayer-Helm 2014 CORESTA CONGRESS - ST46 Québec City, Canada 12-16 October 2014 Background

More information

DMRI Drug Misuse Research Initiative

DMRI Drug Misuse Research Initiative DMRI Drug Misuse Research Initiative Executive Summary Comorbidity in the national psychiatric morbidity surveys Research Report submitted to the Department of Health in February 2004 Report prepared by:

More information

UK E-Cigarette Summit Relative risks of cancer posed by combustible and vapourising forms of nicotine delivery: Evidence from chemical exposures

UK E-Cigarette Summit Relative risks of cancer posed by combustible and vapourising forms of nicotine delivery: Evidence from chemical exposures UK E-Cigarette Summit 2017 Relative risks of cancer posed by combustible and vapourising forms of nicotine delivery: Evidence from chemical exposures Ed Stephens University of St Andrews Scope of presentation

More information

What is combustion and why is the absence of combustion important for heat not burn products

What is combustion and why is the absence of combustion important for heat not burn products What is combustion and why is the absence of combustion important for heat not burn products Global Forum on Nicotine 2017 June 16 th 2017 Thomas Mc Grath PhD PMI R&D, Philip Morris Products S.A., Quai

More information

The electronic cigarette (personal nicotine vaporizer)

The electronic cigarette (personal nicotine vaporizer) The electronic cigarette (personal nicotine vaporizer) Murray Laugesen Health New Zealand Ltd nicotine and tobacco product researchers www.healthnz.co.nz Christchurch, New Zealand (c) www.healthnz.co.nz

More information

Electronic Cigarettes: What we know so far

Electronic Cigarettes: What we know so far Electronic Cigarettes: What we know so far Dr. Lynne Dawkins Drugs and Addictive Behaviours Research Group (DABRG), School of Psychology http://www.uel.ac.uk/psychology/research/drugs What I m going to

More information

Smokeless Tobacco Use in the US Military

Smokeless Tobacco Use in the US Military Murtha Cancer Center The DoD Cancer Center of Excellence Accelerating Progress against Cancer through Collaboration Smokeless Tobacco Use in the US Military 23 Jun 2014 Dr. S. Steve Lee Dr. Kangmin Zhu

More information

Tobacco Harm Reduction Brad Rodu

Tobacco Harm Reduction Brad Rodu Tobacco Harm Reduction Brad Rodu Professor, Department of Medicine James Graham Brown Cancer Center University of Louisville The Smoking Status Quo: Unacceptable The American Anti-Smoking Campaign is 45

More information

Smoke Yields of Tobacco-Specific Nitrosamines in Relation to FTC Tar Level and Cigarette Manufacturer: Analysis of the Massachusetts Benchmark Study

Smoke Yields of Tobacco-Specific Nitrosamines in Relation to FTC Tar Level and Cigarette Manufacturer: Analysis of the Massachusetts Benchmark Study Research Articles Smoke Yields of Tobacco-Specific Nitrosamines in Relation to FTC Tar Level and Cigarette Manufacturer: Analysis of the Massachusetts Benchmark Study Jeffrey E. Harris MD, PhD a SYNOPSIS

More information

The Chemical characterisation of E-device Aerosols

The Chemical characterisation of E-device Aerosols The Chemical characterisation of E-device Aerosols Stuart Martin & Chris Rawlinson CORESTA SSPT ST02 30 th September 2013 Group R&D, British American Tobacco, Southampton, UK Introduction BAT s initial

More information

Toxicological sciences in Beitraege zur Tabakforschung International (BTFI) during the last 55 years

Toxicological sciences in Beitraege zur Tabakforschung International (BTFI) during the last 55 years Toxicological sciences in Beitraege zur Tabakforschung International (BTFI) during the last 55 years Gerhard Scherer 1 and Wolf-Dieter Heller 2 1 ABF Analytisch-Biologisches Forschungslabor GmbH, München,

More information

The importance of offering adult smokers a portfolio of potentially less harmful products

The importance of offering adult smokers a portfolio of potentially less harmful products The importance of offering adult smokers a portfolio of potentially less harmful products International Symposium on Nicotine Technology June 15 th 2017 Thomas Mc Grath, PhD PMI R&D, Philip Morris Products

More information

Physical and chemical properties of cigarette, heated tobacco and e-cigarette aerosols

Physical and chemical properties of cigarette, heated tobacco and e-cigarette aerosols SPS3 N2ff Physical and chemical properties of cigarette, heated tobacco and e-cigarette aerosols Caner U Yurteri, Jennifer Margham, Kevin McAdam, Mark Forster, Chuan Liu, Chris Wright, Derek Mariner, Chris

More information

Satiety Control Through Food Structures Made by Novel Processing:

Satiety Control Through Food Structures Made by Novel Processing: Satiety Control Through Food Structures Made by Novel Processing: Generating Novel Food Structures to Aid Consumer Weight Management Prof Jason Halford Department of Psychological Sciences, University

More information

Western Moist Snuff and Oropharyngeal Cancer

Western Moist Snuff and Oropharyngeal Cancer Western Moist Snuff and Oropharyngeal Cancer A Systematic Review Ali Mohammed Abbas 2010 Supervisor: Maria Nilsson الرحيم الرحمن االله بسم In the name of God, the Beneficent, the Merciful - ii - Acknowledgement

More information

AFLATOXIN M1 CAT. NO. 961AFLMO1M

AFLATOXIN M1 CAT. NO. 961AFLMO1M h AFLATOXIN M1 CAT. NO. 961AFLMO1M Competitive ELISA Immunoassay for the quantitative detection of Aflatoxin M1 in milk, milk powder and cheese. General Aflatoxins are toxic metabolites produced by a variety

More information

Epidemiological evidence on snus (Swedish moist snuff) and health in adults. By Peter Lee

Epidemiological evidence on snus (Swedish moist snuff) and health in adults. By Peter Lee Epidemiological evidence on snus (Swedish moist snuff) and health in adults By Peter Lee Relevant publications specifically on snus Lee, P.N., 2011. Summary of the epidemiological evidence relating snus

More information

The Effect of Puff Duration on Smoke Chemistry

The Effect of Puff Duration on Smoke Chemistry The Effect of Puff Duration on Smoke Chemistry Eun-Jung Han* John Lee, Hae-Geun Shin, Ga-Hee Lim, Hyo-Keun Kim Oct 15, 2014 Contents 1 Introduction 2 Experimental 3 Results & Discussion 4 Conclusion 2

More information

Harmful and potentially harmful constituents in e-cigarettes

Harmful and potentially harmful constituents in e-cigarettes Harmful and potentially harmful constituents in e-cigarettes Prof. Riccardo Polosa Institute of Internal Medicine Centre for the Prevention and Cure of Tabagism University of Catania - ITALY Global Forum

More information

E-Cigarettes: Current Perspective

E-Cigarettes: Current Perspective E-Cigarettes: Current Perspective Aruni Bhatnagar, Ph.D. Professor of Medicine University of Louisville Louisville, KY Electronic Cigarettes E-cigarettes are electronic nicotine delivery systems (ENDS),

More information

Swedish snus: Nicotine, Prevalence, Gateway, Epidemiology of harm and Use for smoking cessation

Swedish snus: Nicotine, Prevalence, Gateway, Epidemiology of harm and Use for smoking cessation Swedish snus: Nicotine, Prevalence, Gateway, Epidemiology of harm and Use for smoking cessation Karl Fagerstrom Ph.D. Smoker s Information Centre Helsingborg Sweden That humanity at large will ever be

More information

00:08 For decades our scientists have endeavoured to reduce the risks of tobacco use and continue to do so today. 00:15

00:08 For decades our scientists have endeavoured to reduce the risks of tobacco use and continue to do so today. 00:15 00:00 British American Tobacco 00:02 00:03 The Electronic Cigarette 00:07 00:08 For decades our scientists have endeavoured to reduce the risks of tobacco use and continue to do so today. 00:15 00:15 Our

More information

SUPER SMOKER EXPERT REPORT FINAL REPORT

SUPER SMOKER EXPERT REPORT FINAL REPORT TOXICOLOGY LABORATORY GASTHUISBERG CAMPUS, O&N2 P8 922, HERESTRAAT 49 D-3000 LEUVEN CATHOLIC UNIVERSITY LEUVEN LEUVEN, 29 June 2007 SUPER SMOKER EXPERT REPORT FINAL REPORT On 28 February 2007 the following

More information

A Coach s Guide to Spit Tobacco Education

A Coach s Guide to Spit Tobacco Education OUTLINE Goal Coaches, players and parents will understand that spit tobacco can lead to use of cigarettes, increases the chances of experimentation with other substances and other unhealthy choices. Objectives

More information

Smoking and Non-Communicable Diseases in Hong Kong

Smoking and Non-Communicable Diseases in Hong Kong Smoking and Non-Communicable Diseases in Hong Kong Current Status and the Way Forward Prof. David Khayat Former Head of Medical Oncology at the Pitié-Salpêtrière in Paris Former President of the National

More information

Changes in TSNA contents during tobacco storage and the effect of temperature and nitrate level on TSNA formation

Changes in TSNA contents during tobacco storage and the effect of temperature and nitrate level on TSNA formation Changes in TSNA contents during tobacco storage and the effect of temperature and nitrate level on TSNA formation HONGZHI SHI 1, RUIYUN WANG 1, LOWELL P. BUSH 2, JUN ZHOU 3, FRANKLIN F. FANNIN 2, RUOSHI

More information

Tobacco Control Policy and Legislation Antero Heloma, MD, PhD Principal Medical Adviser. 20/03/2012 Presentation name / Author 1

Tobacco Control Policy and Legislation Antero Heloma, MD, PhD Principal Medical Adviser. 20/03/2012 Presentation name / Author 1 Tobacco Control Policy and Legislation Antero Heloma, MD, PhD Principal Medical Adviser 20/03/2012 Presentation name / Author 1 Mortality from smoking in 1950-2000 About 63 million people died from smoking

More information